New CSU Treatment: What Is a BTK Inhibitor Medication?
This podcast explains what BTK inhibitors are, how they work inside mast cells, and what this new CSU treatment means for people with chronic hives.
This podcast explains what BTK inhibitors are, how they work inside mast cells, and what this new CSU treatment means for people with chronic hives.
This podcast episode looks at recommendations for clinically diagnosing and treating mast cell activation syndrome (MCAS).
This podcast looks at the severe impact that chronic hives can have on mental health. Find out what the study discovered about CSU, suicide, and why treatment matters.
This podcast episode explains a treatment called Avapritinib for indolent systemic mastocytosis. Find out what the PIONEER study discovered.
Do patients and providers see indolent systemic mastocytosis the same way? We examine a study showing a disconnect in how symptom burden is understood.
In this podcast journal review, we look at how the Tezepelumab shot reduced nasal polyps and improved breathing in a year-long study on chronic sinus swelling.
This podcast explores why some children develop multiple allergic diseases over time and Type 2 inflammation’s role.
In this episode, learn how Type 2 Inflammation links several conditions like asthma, eczema, and nasal polyps, and how it leads to more serious diseases.
This podcast explains how Type 2 inflammation works. Learn about key players like Th2 cells, cytokines, eosinophils and IgE and how they cause swelling.
This episode explores the challenges of living with hives in skin of color, highlighting self-advocacy, building a supportive care team and finding resources.
In this podcast, we discuss hives in skin of color, the lack of images online, and effective, inclusive care options.
This episode explores the history of the eight biologic therapies available for allergic conditions.
End of content
End of content

10304 Eaton Place, Suite 100
Fairfax, VA 22030
Phone: 800-878-4403
Join Our Newsletter
Keep up with the latest news from AAN, right in your inbox! Choose from our eNewsletter, Research or EXHALE newsletters.
🔐 We do not share or sell your information.